#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14368	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2114	669.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1418	1418	C	757	C	738	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14368	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2114	669.1	0	HET	.	.	.	C207T	.	207	207	C	441	441	C	810	C,T	626,157	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26352	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3567	732.0	0	.	n	.	0	T695C	SNP	695	695	T	967	967	C	842	C,T	802,5	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26352	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3567	732.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	1910	1910	G	804	G,A,T	550,230,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26352	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3567	732.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2243	2243	C	780	C	747	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26352	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3567	732.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2317	2317	A	783	A	752	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26352	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3567	732.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2869	2869	C	817	C,T	779,9	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1530	folP	855	855	100.0	folP.l6.c30.ctg.1	1274	116.6	1	SNP	p	R229S	1	.	.	685	687	AGC	895	897	AGC	137;138;140	A;G;C	134;136;138	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4298	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3413	124.8	1	SNP	p	S91F	1	.	.	271	273	TTC	551	553	TTC	140;139;138	T;T;C,A	138;135;134,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4298	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3413	124.8	1	SNP	p	G95N	0	.	.	283	285	GGC	563	565	GGC	141;140;140	G;G;C,T	136;133;133,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4298	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3413	124.8	1	SNP	p	D95G	1	.	.	283	285	GGC	563	565	GGC	141;140;140	G;G;C,T	136;133;133,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1354	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1290	104.3	1	SNP	p	G45D	0	.	.	133	135	GGC	469	471	GGC	166;166;163	G;G;C	160;163;161	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	672	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1012	65.7	0	.	n	.	0	A197.	DEL	197	197	A	524	524	A	163	A	147	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4876	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2928	164.7	1	SNP	p	D86N	0	.	.	256	258	GAC	594	596	GAC	183;185;188	G,T;A;C	176,1;176;183	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4876	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2928	164.7	1	SNP	p	S87R	1	.	.	259	261	CGT	597	599	CGT	190;196;199	C,A;G;T	179,4;188;187	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4876	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2928	164.7	1	SNP	p	R87W	0	.	.	259	261	CGT	597	599	CGT	190;196;199	C,A;G;T	179,4;188;187	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4876	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2928	164.7	1	SNP	p	R87I	0	.	.	259	261	CGT	597	599	CGT	190;196;199	C,A;G;T	179,4;188;187	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4876	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2928	164.7	1	SNP	p	S88P	0	.	.	262	264	TCC	600	602	TCC	199;199;200	T;C;C	189;191;191	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3462	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2660	128.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1554	1556	GGC	168;163;164	G;G;C	164;160;159	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3480	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2326	144.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1296	1298	GCC	175;177;180	G;C;C	171;172;174	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3480	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2326	144.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1299	1301	ATG	177;176;177	A;T;G	172;172;173	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3480	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2326	144.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1311	1313	ACC	182;184;182	A;C;C	173;176;176	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3480	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2326	144.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1311	1313	ACC	182;184;182	A;C;C	173;176;176	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3480	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2326	144.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1812	1814	ACC	161;159;158	A,C;C;C,T	145,1;149;148,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3480	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2326	144.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1866	1868	GCG	151;152;151	G;C;G	145;147;148	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3480	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2326	144.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1866	1868	GCG	151;152;151	G;C;G	145;147;148	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3480	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2326	144.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1989	1991	GGT	133;133;133	G,A;G;T,C	123,2;128;122,3	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3480	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2326	144.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1998	2000	AGC	127;127;124	A,G;G;C	116,3;120;118	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3480	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2326	144.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2016	2018	CCG	98;100;99	C,G;C,T;G,T	83,4;86,1;84,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5738	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3113	182.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1651	1653	CCG	229;228;229	C;C,T;G	205;207,6;206	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2190	porA	1146	1146	99.91	porA.l6.c17.ctg.1	1769	122.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	553	553	C	152	C	145	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3160	porB1b	1038	1038	100.0	porB1b.l6.c17.ctg.1	1530	202.6	1	SNP	p	G120K	1	.	.	358	360	AAG	626	628	AAG	246;245;245	A,G,C;A,G;G,T	229,4,2;233,3;224,4	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3160	porB1b	1038	1038	100.0	porB1b.l6.c17.ctg.1	1530	202.6	1	SNP	p	N121D	0	.	.	361	363	AAC	629	631	AAC	247;247;247	A,G;A,C;C	228,9;233,3;235	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3160	porB1b	1038	1038	100.0	porB1b.l6.c17.ctg.1	1530	202.6	1	SNP	p	A121N	1	.	.	361	363	AAC	629	631	AAC	247;247;247	A,G;A,C;C	228,9;233,3;235	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10712	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4923	215.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1188	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1132	104.1	1	SNP	p	V57M	1	.	.	169	171	ATG	674	676	ATG	237;238;240	A;T;G	228;229;232	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
